Author: Luo Xiaodong, Department of Nuclear Medicine, Henan Tianyou Cancer Hospital of Integrated Traditional Chinese and Western Medicine
Thyroid cancer is a
Malignancy of thyroid follicular cells or C cells (parafollicular cells).
According to tumor origin and degree of differentiation,
Thyroid cancer is mainly divided into:
Papillary Thyroid Cancer (PTC) ,
Follicular Thyroid Carcinoma (FTC),
medullary thyroid carcinoma (MTC) ,
Anaplastic Thyroid Cancer (ATC) .
Papillary Thyroid Cancer (PTC) and Follicular Thyroid Cancer (FTC)
Collectively called differentiated thyroid cancer (DTC) .
Differentiated thyroid cancer (DTC) accounts for 95% of thyroid cancers.
Among them, papillary thyroid carcinoma (PTC) is the most common.
It accounts for about 90% of all thyroid cancers .
Thyroid cancer we often say,
Unless otherwise specified,
Often referred to as differentiated thyroid cancer (DTC).
Differentiated thyroid cancer (DTC) has a good prognosis,
(A cowardly soldier, weak in combat)
Medullary thyroid carcinoma (MTC )
(Good soldier, average combat effectiveness)
Anaplastic thyroid carcinoma (ATC) has the worst prognosis,
(special forces, strong combat effectiveness)
One sentence summary:
Thyroid cancer unless otherwise specified,
Usually referred to as differentiated thyroid cancer (DTC) .
————End of this article————
references:
“Guidelines for the diagnosis and treatment of thyroid cancer” (2022 edition)
Chinese Society of Clinical Oncology (CSCO) Guidelines for the diagnosis and treatment of differentiated thyroid cancer 2021
Analysis of prognostic factors and treatment decisions for anaplastic thyroid carcinoma［J］. China Oncology, 2021, 31(3): 212-220.